We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Realm Thera. | RLM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 11.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 11.50 | 11.50 |
| Top Posts |
|---|
Posted at 21/2/2019 15:40 by cjohn I think one factor putting off new investors is the complication of the conversion of ordinary shares into ADSs. |
Posted at 15/2/2018 10:33 by edmonda Positive clinical and business update released today and new research note with valuation update now out from Equity Dev.Free access here: … AND you can see the CEO of Realm present at the next ED Private Investor Forum in London on Wed 28 March, register here: |
Posted at 15/1/2018 13:07 by aim_trader Realm Therapeutics will be presenting to investors at the upcoming Proactive One2One Forum on the evening of 25th January in London. For details and registration, please click here: |
Posted at 16/10/2017 15:52 by cerrito The costs for this last fund raising seem very high but they did get 4 new investors to take 55m of the 66m new shares.PS are there holders who can set up a new thread? |
Posted at 30/1/2017 13:32 by hannahh If you would like to listen to the presentation given by CEO Alex Martin at our previous investor forum the recording is now available at: hxxps://www.equitydeKind regards, The Equity Development team |
Posted at 17/1/2017 14:12 by hannahh If you would like to hear Alex Martin, Chief Executive Officer, present on behalf of Realm Therapeutics he will be appearing at our next investor forum on the evening of Wednesday 25th of January. Also appearing will be the management of Ergomed and Kromek.To learn more about the forum and to register for free please follow this link: hxxps://www.eventbri Thanks, The Equity Development team |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
